Lupin launches Luforbec 100/6 μg pMDI
It is the first branded generic alternative to Fostair 100/6 μg pMDI for the treatment of asthma and COPD in the UK
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Luforbec
Lupin gets UK marketing authorisation for Luforbec 100/6 µg pMDI
Luforbec 100/6 µg pMDI is indicated for regular treatment of asthma and for the symptomatic treatment of patients with severe COPD